Evidence map›Paper›PMID 34680761›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Consumption of Antibacterials for Systemic Use in Slovakia: A National Study and the Quality Indicators for Outpatient Antibiotic Use.

Tomas Tesar, Lucia Masarykova, Lubica Lehocka, Slavka Porubcova, Monika Cicova, Martin Wawruch

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tomas TesarDepartment of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia.ORCID 0000-0002-0023-4574
Lucia MasarykovaDepartment of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia.
Lubica LehockaDepartment of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia.
Slavka PorubcovaDepartment of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia.
Monika CicovaDepartment of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia.
Martin WawruchInstitute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper aims to analyse the consumption of antibiotics in the Slovak health care system from 2011 to 2020. The data source on the consumption of antibiotics is sales data from SUKL and NCZI. The study employed the ATC/DDD Index and focused on the consumption of antibiotics in the primary care sector. Total antibiotic consumption decreased from 19.21 DID in 2011 to 13.16 DID in 2020. Consumption of beta-lactamase-sensitive penicillins, expressed as a percentage of the total consumption of antibiotics, decreased from 8.4% in 2011 to 4.2% in 2020. Consumption of the combination of penicillins, including beta-lactamase inhibitor, expressed as a percentage of the total consumption of antibiotics, increased from 16.2% in 2011 to 17.9% in 2020. Consumption of third- and fourth-generation cephalosporins, expressed as the percentage of the total consumption of antibiotics, increased from 2.0% in 2011 to 4.6% in 2020. Consumption of fluoroquinolones, expressed as the percentage of the total consumption of antibiotics, decreased from 10.7% in 2011 to 8.6% in 2020. Overall, antibiotic consumption significantly changed in Slovakia from 2011 to 2020. The ratio of the consumption of broad-spectrum to the consumption of narrow-spectrum penicillins, cephalosporins and macrolides decreased from 14.98 in 2011 to 13.38 in 2020.

Indexed as

anatomical therapeutic chemical classification system (ATC)antibiotic consumption (AMC)defined daily dose (DDD)/1000 patient-daysquality indicators

Identifiers

PMID34680761
PMCPMC8532770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.